“Baseline and Dynamic Changes in Skeletal Muscle Mass As Predictive Biomarkers in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab: Predictive Value of Sarcopenia in MRCC”. 2025. Radiology and Oncology 59 (4): 624-34. https://www.radioloncol.com/index.php/ro/article/view/4685.